Late treatment with imatinib mesylate ameliorates radiation-induced lung fibrosis in a mouse model.

The earlier therapy start appeared to be slightly more effective in reducing CT signs of lung fibrosis than a later therapy, but this tendency did not reach statistical significance (P > 0.1).

also in 111,027 other papers